Secobarbital/brallobarbital/hydroxyzine
Combination drug used as a sedative and hypnotic
Secobarbital/brallobarbital/hydroxyzine is a combination medication used primarily as a sedative and hypnotic. It is known under the brand name Vesparax. This medication is used to induce sleep and reduce anxiety in patients undergoing medical procedures or experiencing severe insomnia.
Components[edit | edit source]
The combination drug consists of three active ingredients:
- Secobarbital: A barbiturate that acts as a central nervous system depressant. It is used for its sedative and hypnotic properties.
- Brallobarbital: Another barbiturate with similar effects to secobarbital, contributing to the overall sedative effect of the combination.
- Hydroxyzine: An antihistamine with sedative properties, which also helps to reduce anxiety and tension.
Mechanism of Action[edit | edit source]
The combination of secobarbital, brallobarbital, and hydroxyzine works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits activity in the brain. This results in a calming effect, making it easier for patients to fall asleep and stay asleep.
Uses[edit | edit source]
Secobarbital/brallobarbital/hydroxyzine is primarily used for:
- Inducing sleep in patients with severe insomnia.
- Reducing anxiety and tension before medical procedures.
- Providing sedation in various clinical settings.
Administration[edit | edit source]
The medication is typically administered orally in tablet form. The dosage and duration of treatment depend on the patient's condition and response to the medication.
Side Effects[edit | edit source]
Common side effects of this combination drug include:
- Drowsiness
- Dizziness
- Dry mouth
- Headache
Serious side effects may include:
- Respiratory depression
- Confusion
- Allergic reactions
Precautions[edit | edit source]
Patients should be monitored for signs of respiratory depression and allergic reactions. The use of this medication is contraindicated in patients with a history of substance abuse or respiratory disorders.
Discontinuation[edit | edit source]
The use of secobarbital/brallobarbital/hydroxyzine has declined due to the development of newer, safer sedative and hypnotic medications. It is important to taper off the medication gradually to avoid withdrawal symptoms.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
